![Frontiers | Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management Frontiers | Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management](https://www.frontiersin.org/files/Articles/713700/fendo-12-713700-HTML/image_m/fendo-12-713700-g001.jpg)
Frontiers | Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management
![Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models | npj Breast Cancer Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-022-00397-y/MediaObjects/41523_2022_397_Fig1_HTML.png)
Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models | npj Breast Cancer
![Endocrine Therapy in Breast Cancer: Making Sense of the 'Word Salad' - American Association for Cancer Research (AACR) Endocrine Therapy in Breast Cancer: Making Sense of the 'Word Salad' - American Association for Cancer Research (AACR)](https://www.aacr.org/wp-content/uploads/2022/07/ER-explainer-graphic_larger.jpg)
Endocrine Therapy in Breast Cancer: Making Sense of the 'Word Salad' - American Association for Cancer Research (AACR)
![Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials - The Lancet Oncology Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials - The Lancet Oncology](https://www.thelancet.com/cms/attachment/28f62488-d818-4e72-ba24-1636b3b8d894/gr1.jpg)
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials - The Lancet Oncology
![ICARE Social Media Post February 2020Medication Use for Risk Reduction – Inherited Cancer Registry (ICARE) ICARE Social Media Post February 2020Medication Use for Risk Reduction – Inherited Cancer Registry (ICARE)](https://inheritedcancer.net/wp-content/uploads/picture_post21120.png)
ICARE Social Media Post February 2020Medication Use for Risk Reduction – Inherited Cancer Registry (ICARE)
![Women with Elevated Breast Cancer Risk Could See Mortality Benefit from Estrogen-Blocking Drugs | Lombardi Comprehensive Cancer Center | Georgetown University Women with Elevated Breast Cancer Risk Could See Mortality Benefit from Estrogen-Blocking Drugs | Lombardi Comprehensive Cancer Center | Georgetown University](https://lombardi.georgetown.edu/wp-content/uploads/2022/12/pill-bottle-and-hands.jpg)
Women with Elevated Breast Cancer Risk Could See Mortality Benefit from Estrogen-Blocking Drugs | Lombardi Comprehensive Cancer Center | Georgetown University
![IJMS | Free Full-Text | Natural Anti-Estrogen Receptor Alpha Antibodies Able to Induce Estrogenic Responses in Breast Cancer Cells: Hypotheses Concerning Their Mechanisms of Action and Emergence IJMS | Free Full-Text | Natural Anti-Estrogen Receptor Alpha Antibodies Able to Induce Estrogenic Responses in Breast Cancer Cells: Hypotheses Concerning Their Mechanisms of Action and Emergence](https://pub.mdpi-res.com/ijms/ijms-19-00411/article_deploy/html/images/ijms-19-00411-g002.png?1521048120)
IJMS | Free Full-Text | Natural Anti-Estrogen Receptor Alpha Antibodies Able to Induce Estrogenic Responses in Breast Cancer Cells: Hypotheses Concerning Their Mechanisms of Action and Emergence
![Cancers | Free Full-Text | Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer Cancers | Free Full-Text | Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer](https://pub.mdpi-res.com/cancers/cancers-12-01477/article_deploy/html/images/cancers-12-01477-ag.png?1591405196)
Cancers | Free Full-Text | Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer
![Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy - ScienceDirect Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960076019300366-ga1.jpg)